The fundraise was co-led by new investors OrbiMed Advisors and Arix Bioscience plc and included investment from RA Capital and Rock Springs Capital. Existing investors New Enterprise Associates,
The post Imara closes $63m Series B cross-over financing appeared first on Pharmaceutical Business review.
Original Article: Imara closes $63m Series B cross-over financing